Latest News
AFT Pharmaceuticals South Africa latest news
Stay updated with the latest advancements and breakthroughs in the South Africa pharmaceutical industry.
November 28, 2025
AFT Pharmaceuticals SA acquires the Hospital Division of Pharma Dynamics
AFT Pharmaceuticals SA (Pty) Ltd (‘AFT SA’) announces it has successfully completed the acquisition of the Hospital Division business of Pharma Dy…
November 20, 2025
AFT delivers 10th consecutive first half revenue increase
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today reports a strong first-half performance for the six months to 30 September 2025, with revenue growing 3…
September 25, 2025
On track for $300m FY27 revenue; positive iron IV study result
– Sales tracking in line with $300 million FY27 revenue target – Clinical trial supports the potential patient benefits of novel iron IV development …
May 26, 2025
AFT and Hikma extend US Maxigesic Cooperation
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) today announces it has extended its US Maxigesic® licensing agreement with Hikma Pharmaceuticals….
April 24, 2024
AFT, Massey Ventures, Gilles McIndoe to develop scar treatment
AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….
March 5, 2024
AFT makes further progress in international markets
AFT Pharmaceuticals provides an update on recent progress it has made in international markets….
February 19, 2024
AFT updates operating profit guidance to $23m to $25m
AFT Pharmaceuticals today announces an update to guidance for the financial year to the end of March 2024 (FY24)….
January 19, 2024
AFT further broadens R&D pipeline with new product candidate for Vulva Lichen Sclerosus
AFT Pharmaceuticals announces it has entered into a further partnership with one of its long-standing research and development partners, Belgium’s H…
January 17, 2024
AFT poised to accelerate momentum in 2024
As the new year commences, AFT Pharmaceuticals is looking forward to building upon the significant progress made during 2023. Last year we moved on fr…
January 8, 2024
AFT broadens R&D pipeline with new product candidate in Burning Mouth Syndrome
AFT Pharmaceuticals today announces that it has entered into a partnership with one of its research and development partners, Belgium’s Hyloris Phar…
November 24, 2023
AFT Pharma reports growth and global expansion
FINANCIAL RESULTS FOR THE SIX MONTHS TO 30 SEPTEMBER 2023…